entertainment -WSS

entertainment

author：explore 2025-09-29 22:51:20 - browse：1

Illustration of researchers working among oversized pill bottles, lab equipment, and medicine for story about the development of obesity medications – health and pharma coverage from STAT — Molly Ferguson for STAT

The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to develop their own obesity treatments, with most of them trying to emulate the same approach as the blockbuster products.

Nearly 70 obesity treatments are in development, and about two-thirds use a similar mechanism as Wegovy and Mounjaro, according to the STAT Obesity Drug Tracker, a new database compiled by STAT. There are also a minority of companies pursuing entirely different approaches, hoping that they will stand out among the field.

The tracker, which will be updated with significant developments each quarter, gives a sense of what new mechanisms could hit the market, how they would be delivered, and which companies are running the most trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

hotspot

WSS

Arena BioWorks launches in Cambridge to speed drug discovery

Ascension's ugly legal battle over care for poor patients in Texas

Ascension's ugly legal battle over care for poor patients in Texas

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Overprescribed: High cost isn't America's only drug problem

Wikipedia

entertainment

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

STAT Virtual Event: JPM Recap, Live!

DIEP, the 'gold standard' of breast reconstruction, is under threat

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

At JPM 2024, hospital systems pitch financial strength to investors

Medical leaders decry Supreme Court decision on affirmative action

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Alkermes shareholders re

Alzheimer's risk factor APOE4 may be a distinct form of the disease

entertainment

STAT Virtual Event: JPM Recap, Live!

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Male doctors called my cancer incurable. A female doctor showed it wasn't

First Opinion on colorectal cancer screening: letter and response

leisure time

hotspot

explore

knowledge